Professional background
Since 2025 Coordinator of the RESPIrenT group (RESeau de Pneumologie en Innovation et Recherche translaTionnelle)
Since 2023 Research director (INSERM), CRCTB – INSERM U1045
Since 2016 Director of the Pathophysiology of the pulmonary circulation team (CRCTB, INSERM U1045), University of Bordeaux
2000 – 2023 Research officer (INSERM), Centre de Recherche Cardio-Thoracique de Bordeaux (CRCTB) – INSERM U1045
2005 6 months in the laboratory of Pr E. Rousseau – Department of Physiology and biophysics – Sherbrooke – Canada
1997 – 2000 Post-doctoral researcher, School of Biomedical Sciences (Laboratory of Pr D.J. Beech)– Leeds – England
1997 Post-doctoral researcher, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC) – CNRS – Sophia-antipolis – France
1997 PhD in biological and medical sciences, University of Bordeaux
Funding
Hemangiol patent royalties (2020 – 2029)
Prematuration grant (2025 – 2026)
ANRT – CIFRE grant (2019 – 2023)
Fondation du souffle (2020-2022)
Fondation Bordeaux Université – fonds pour les maladies chroniques (2019-2020)
Patents
2022 – OP2113 in the vasculitides (PCT/EP2022/068064)
2017 – OP2113 and its potential applications in various pathologies, including pulmonary hypertension and pulmonary arterial hypertension (WO 2017/0422671A1)